Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
0.7556
-0.0207 (-2.67%)
Apr 29, 2025, 4:00 PM EDT - Market closed

Palisade Bio Statistics

Total Valuation

Palisade Bio has a market cap or net worth of $3.32 million. The enterprise value is -$6.34 million.

Market Cap 3.32M
Enterprise Value -6.34M

Important Dates

The next estimated earnings date is Monday, May 12, 2025, after market close.

Earnings Date May 12, 2025
Ex-Dividend Date n/a

Share Statistics

Palisade Bio has 4.40 million shares outstanding. The number of shares has increased by 210.62% in one year.

Current Share Class 4.40M
Shares Outstanding 4.40M
Shares Change (YoY) +210.62%
Shares Change (QoQ) +44.03%
Owned by Insiders (%) 0.50%
Owned by Institutions (%) 2.29%
Float 4.09M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.28
P/TBV Ratio 0.44
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.24, with a Debt / Equity ratio of 0.02.

Current Ratio 3.24
Quick Ratio 3.05
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1,238.25

Financial Efficiency

Return on equity (ROE) is -153.55% and return on invested capital (ROIC) is -96.02%.

Return on Equity (ROE) -153.55%
Return on Assets (ROA) -74.50%
Return on Invested Capital (ROIC) -96.02%
Return on Capital Employed (ROCE) -194.39%
Revenue Per Employee n/a
Profits Per Employee -$1.80M
Employee Count 8
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -87.51% in the last 52 weeks. The beta is 1.38, so Palisade Bio's price volatility has been higher than the market average.

Beta (5Y) 1.38
52-Week Price Change -87.51%
50-Day Moving Average 0.79
200-Day Moving Average 2.32
Relative Strength Index (RSI) 51.34
Average Volume (20 Days) 43,920

Short Selling Information

The latest short interest is 53,241, so 1.21% of the outstanding shares have been sold short.

Short Interest 53,241
Short Previous Month 176,377
Short % of Shares Out 1.21%
Short % of Float 1.30%
Short Ratio (days to cover) 0.56

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -14.86M
Pretax Income -13.50M
Net Income -14.44M
EBITDA -14.86M
EBIT -14.86M
Earnings Per Share (EPS) -$10.19
Full Income Statement

Balance Sheet

The company has $9.83 million in cash and $169,000 in debt, giving a net cash position of $9.66 million or $2.20 per share.

Cash & Cash Equivalents 9.83M
Total Debt 169,000
Net Cash 9.66M
Net Cash Per Share $2.20
Equity (Book Value) 7.49M
Book Value Per Share 2.71
Working Capital 7.26M
Full Balance Sheet

Cash Flow

Operating Cash Flow -12.19M
Capital Expenditures n/a
Free Cash Flow -12.19M
FCF Per Share -$2.77
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Palisade Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -210.62%
Shareholder Yield -210.62%
Earnings Yield -434.60%
FCF Yield -367.03%

Analyst Forecast

The average price target for Palisade Bio is $23.00, which is 2,943.94% higher than the current price. The consensus rating is "Strong Buy".

Price Target $23.00
Price Target Difference 2,943.94%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -35.22%
Stock Forecasts

Stock Splits

The last stock split was on April 8, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date Apr 8, 2024
Split Type Reverse
Split Ratio 0.0666667:1

Scores

Altman Z-Score n/a
Piotroski F-Score 1